Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia

Journal of Medical Virology

Volumn 82, Issue 11, 2010, Pages 1889-1898

  Mora, Mónica Viviana Alvarado ^a   Romano, Camila Malta ^a   Gomes Gouvêa, Michele Soares ^a   Gutiérrez, Maria Fernanda ^b   Carrilho, Flair José ^a   Pinho, João Renato Rebello ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

Author keywords

Bayesian analysis; Blood donors; Colombia; Genotype 1b; Hepatitis C virus

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BAYES THEOREM; BLOOD; BLOOD DONOR; CLASSIFICATION; COLOMBIA; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; VIROLOGY;

ADULT; BAYES THEOREM; BLOOD DONORS; COLOMBIA; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 79952117553     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21908     Document Type: Article

References (54)

1. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. 1991. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325: 1325-1329.
2. Amorim RM, Oliveira CP, Wyant PS, Cerqueira DM, Camara GN, Flores LS, Martins RM, Martins CR. 2004. Hepatitis C virus genotypes in blood donors from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz 99: 895-897.
3. Andrade AF, Oliveira-Silva M, Silva SG, Motta IJ, Bonvicino CR. 2006. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Mem Inst Oswaldo Cruz 101: 673-676.
4. Beltran M, Navas MC, De la Hoz F, Mercedes Munoz M, Jaramillo S, Estrada C, Del Pilar Cortes L, Arbelaez MP, Donado J, Barco G, Luna M, Uribe GA, de Maldonado A, Restrepo JC, Correa G, Borda P, Rey G, de Neira M, Estrada A, Yepes S, Beltran O, Pacheco J, Villegas I, Boshell J. 2005. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J Clin Virol 34: S33-S38.
5. Blood bank situation in Latin America. 1996. Serological markers for communicable diseases in blood donors. Epidemiol Bull 19: 12-14.
6. Booth JC, O'Grady J, Neuberger J. 2001. Clinical guidelines on the management of hepatitis C. Gut 49: I1-I21.
7. Bukh J, Purcell RH, Miller RH. 1993. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 90: 8234-8238.
8. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, de Lamballerie X, de Micco P. 2006. Analysis of the 5' noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 44: 2051-2056.
9. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, Croce L, Tiribelli C, Campello C. 2002. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 68: 352-356.
10. Di Lello F, Garcia G, Kott V, Sookoian S, Campos R. 2008. Diversity of hepatitis C virus genotype 1b in Buenos Aires, Argentina: Description of a new cluster associated with response to treatment. J Med Virol 80: 619-627.
11. Di Lello FA, Pineiro YLFG, Munoz G, Campos RH. 2009. Diversity of hepatitis B and C viruses in Chile. J Med Virol 81: 1887-1894.
12. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
13. Echevarria JM, Leon P. 2003. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica 19: 1583-1591.
14. Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V, Moncharmont P, Maisoneuve P, du Puy-Montbrun MC, Lyon-Caen D, Courouce AM. 2000. Hepatitis C virus: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 79: 138-144.
15. Enomoto N, Takada A, Nakao T, Date T. 1990. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 170: 1021-1025.
16. Espirito-Santo MP, Carneiro MA, Reis NR, Kozlowski AG, Teles SA, Lampe E, Yoshida CF, Martins RM. 2007. Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis. Braz J Med Biol Res 40: 545-550.
17. Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186-194.
18. Ewing B, Hillier L, Wendl MC, Green P. 1998. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8: 175-185.
19. Ferraro D, Genovese D, Argentini C, Giordano V, Pizzillo P, Stroffolini T, Craxi A, Rapicetta M, Di Stefano R. 2008. Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: The Camporeale model. J Med Virol 80: 1723-1731.
20. Furione M, Simoncini L, Gatti M, Baldanti F, Grazia Revello M, Gerna G. 1999. HCV genotyping by three methods: Analysis of discordant results based on sequencing. J Clin Virol 13: 121-130.
21. Garcia-Montalvo BM, Macossay-Castillo M. 2007. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan. Mexico Transfus Med 17: 488-490.
22. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, Parker D, Barbara JA, Contreras M, Aloysius S. 1990. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 335: 1419-1422.
23. Garson JA, Ring CJ, Tuke PW. 1991. Improvement of HCV genome detection with "short" PCR products. Lancet 338: 1466-1467.
24. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foca A, Piazza M. 1997. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy. Hepatology 26: 1006-1011.
25. Halfon P, Ouzan D, Khiri H, Feryn JM. 1997. Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie. J Med Virol 52: 391-395.
26. Ishii K, Tanaka Y, Yap CC, Aizaki H, Matsuura Y, Miyamura T. 1999. Expression of hepatitis C virus NS5B protein: Characterization of its RNA polymerase activity and RNA binding. Hepatology 29: 1227-1235.
27. Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A. 2006. Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 13: 19-27.
28. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. 2003. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 69: 367-375.
29. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339: 237-238.
30. Liu P, Xiang K, Tang H, Zhang W, Wang X, Tong X, Takebe Y, Yang R. 2008. Molecular epidemiology of human immunodeficiency virus type 1 and hepatitis C virus in former blood donors in central China. AIDS Res Hum Retroviruses 24: 1-6.
31. Maertens G, Stuyver L. 1997. Genotypes and genetic variation of Hepatitis C virus In The molecular medicine of viral Hepatitis. England: John Wiley & Sons. pp. 182-223.
32. Martell M, Briones C, de Vicente A, Piron M, Esteban JI, Esteban R, Guardia J, Gomez J. 2004. Structural analysis of hepatitis C RNA genome using DNA microarrays. Nucleic Acids Res 32: e90.
33. Martins RM, Vanderborght BO, Yoshida CF. 1998. Hepatitis C virus genotypes among blood donors from different regions of Brazil. Mem Inst Oswaldo Cruz 93: 299-300.
34. Munoz G, Velasco M, Thiers V, Hurtado C, Brahm J, Larrondo-Lillo M, Guglielmetti A, Smok G, Brechot C, Lamas E. 1998. Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population. Rev Med Chil 126: 1035-1042.
35. Nakano T, Lu L, Liu P, Pybus OG. 2004. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190: 1098-1108.
36. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. 1995. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 122: 161-168.
37. Pasquier C, Njouom R, Ayouba A, Dubois M, Sartre MT, Vessiere A, Timba I, Thonnon J, Izopet J, Nerrienet E. 2005. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 77: 390-398.
38. Pawlotsky JM. 2003. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 59: 1-11.
39. Posada D, Crandall KA. 1998. MODELTEST: Testing the model of DNA substitution. Bioinformatics 14: 817-818.
40. Romano CM, de Carvalho-Mello IMVG, Jamal LF, Melo FL, Iamarino A, Motoki M, Pinho JRR, Holmes EC, Zanotto PMA. VGDN consortium, 2010.Social networks shape the transmission dynamics of hepatitis C virus. PLoS One (in press).
41. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. 2000. Changes in the epidemiology of hepatitis C infection in Germany: Shift in the predominance of hepatitis C subtypes. J Med Virol 60: 122-125.
42. Salemi M, Vandamme AM. 2002. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J Mol Evol 54: 62-70.
43. Sanchez JL, Sjogren MH, Callahan JD, Watts DM, Lucas C, Abdel-Hamid M, Constantine NT, Hyams KC, Hinostroza S, Figueroa-Barrios R, Cuthie JC. 2000. Hepatitis C in Peru: Risk factors for infection, potential iatrogenic transmission, and genotype distribution. Am J Trop Med Hyg 63: 242-248.
44. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. 2003. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109: 187-193.
45. Schmunis GA, Cruz JR. 2005. Safety of the blood supply in Latin America. Clin Microbiol Rev 18: 12-29.
46. Schmunis GA, Zicker F, Cruz JR, Cuchi P. 2001. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am J Trop Med Hyg 65: 924-930.
47. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolbeg J, Urdea MS. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74: 2391-2399.
48. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. 1997. The origin f hepatitis C virus genotypes. J Gen Virol 78: 321-328.
49. Soza A, Arrese M, Gonzalez R, Alvarez M, Perez RM, Cortes P, Patillo A, Riquelme A, Riqueme A. 2004. Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C. Ann Hepatol 3: 146-151.
50. Spada E, Ciccaglione AR, Dettori S, Chionne P, Kondili LA, Amoroso P, Guadagnino V, Greco M, Rapicetta M. 1998. Genotyping HCV isolates from Italy by type-specific PCR assay in the core region. Res Virol 149: 209-218.
51. Suzuki T, Aizaki H, Murakami K, Shoji I, Wakita T. 2007. Molecular biology of hepatitis C virus. J Gastroenterol 42: 411-423.
52. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analyss tools. Nucleic Acids Res 25: 4876-4882.
53. WHO. 1991. Consensus statement on screening of blood donations for infectious agents transmissible through blood transfusion. Geneva: World Health Organization Global Programme on AIDS/League of Red Cross and Red Crescent Societies. p 13.
54. Zwickl DJ. 2006. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion: The University of Texas at Austin.